Charles F Wagner Jr Vertex Pharmaceuticals Inc (VRTX) insider trading activity

Charles F Wagner Jr is EVP & Chief Financial Officer of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 44,137 shares of VRTX, which is worth approximately $20.6 Million. The most recent transaction as insider was on Nov 11, 2024, when has been sold 3,000 shares (Common Stock) at a price of $518.27 per share, resulting in proceeds of $1,554,810. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.1K

6.36% 3M change

5.47% 12M change

Total Value Held $20.6 Million

CHARLES F WAGNER Jr Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 11 2024	SELL Open market or private sale	$1,554,810 $518.27 p/Share	3,000 Reduced 6.36%	44,137 Common Stock
Jun 03 2024	SELL Open market or private sale	$1,495,000 $460.0 p/Share	3,250 Reduced 6.45%	47,137 Common Stock
May 28 2024	SELL Open market or private sale	$1,478,067 $454.79 p/Share	3,250 Reduced 6.06%	50,387 Common Stock
Feb 23 2024	SELL Payment of exercise price or tax liability	$1,428,793 $431.79 p/Share	3,309 Reduced 5.82%	53,583 Common Stock
Feb 20 2024	SELL Payment of exercise price or tax liability	$1,182,670 $420.58 p/Share	2,812 Reduced 4.71%	56,892 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$1,590,037 $424.01 p/Share	3,750 Reduced 5.91%	59,704 Common Stock
Feb 09 2024	SELL Payment of exercise price or tax liability	$1,102,083 $422.74 p/Share	2,607 Reduced 3.95%	63,454 Common Stock
Feb 07 2024	BUY Grant, award, or other acquisition	-	7,114 Added 9.72%	66,061 Common Stock
Feb 06 2024	BUY Grant, award, or other acquisition	-	15,254 Added 20.56%	58,947 Common Stock
Jan 02 2024	SELL Open market or private sale	$1,215,000 $405.0 p/Share	3,000 Reduced 6.42%	43,693 Common Stock
Nov 20 2023	SELL Open market or private sale	$1,049,640 $349.88 p/Share	3,000 Reduced 6.04%	46,693 Common Stock
Mar 24 2023	SELL Open market or private sale	$539,911 $305.38 p/Share	1,768 Reduced 3.44%	49,611 Common Stock
Mar 17 2023	SELL Open market or private sale	$595,020 $297.51 p/Share	2,000 Reduced 3.75%	51,379 Common Stock
Mar 13 2023	SELL Open market or private sale	$782,577 $293.54 p/Share	2,666 Reduced 4.76%	53,379 Common Stock
Mar 10 2023	SELL Open market or private sale	$606,960 $290.69 p/Share	2,088 Reduced 3.59%	56,045 Common Stock
Feb 24 2023	SELL Payment of exercise price or tax liability	$956,408 $289.12 p/Share	3,308 Reduced 5.38%	58,133 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$1,098,187 $292.85 p/Share	3,750 Reduced 5.75%	61,441 Common Stock
Feb 13 2023	SELL Payment of exercise price or tax liability	$1,488,913 $298.26 p/Share	4,992 Reduced 7.11%	65,191 Common Stock
Feb 10 2023	SELL Payment of exercise price or tax liability	$796,751 $294.33 p/Share	2,707 Reduced 3.71%	70,183 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	30,026 Added 29.18%	72,890 Common Stock
May 02 2022	SELL Open market or private sale	$89,046 $259.61 p/Share	343 Reduced 0.8%	42,730 Common Stock
Apr 29 2022	SELL Payment of exercise price or tax liability	$151,065 $276.17 p/Share	547 Reduced 1.25%	43,073 Common Stock
Apr 01 2022	SELL Open market or private sale	$683,094 $264.56 p/Share	2,582 Reduced 5.59%	43,620 Common Stock
Mar 17 2022	SELL Open market or private sale	$794,621 $250.59 p/Share	3,171 Reduced 6.42%	46,202 Common Stock
Feb 24 2022	SELL Payment of exercise price or tax liability	$498,786 $227.86 p/Share	2,189 Reduced 4.25%	49,373 Common Stock

Also insider at

TJX

TJX COMPANIES INC Consumer Cyclical

CFW